Therefore, we propose that ALMS1 silencing leads to the inhibition of SMAD2 phosphorilation, which may prevent the protector effect against fibrosis associated with this protein and also trigger the systemic fibrosis displayed by ALMS patients. This evidence concerns the gene ALMS1 and Alstrom syndrome.